Your browser doesn't support javascript.
loading
CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.
Somers, Klaartje; Chudakova, Daria A; Middlemiss, Shiloh M C; Wen, Victoria W; Clifton, Molly; Kwek, Alan; Liu, Bing; Mayoh, Chelsea; Bongers, Angelika; Karsa, Mawar; Pan, Sukey; Cruikshank, Sarah; Scandlyn, Marissa; Hoang, Wendi; Imamura, Toshihiko; Kees, Ursula R; Gudkov, Andrei V; Chernova, Olga B; Haber, Michelle; Norris, Murray D; Henderson, Michelle J.
Afiliação
  • Somers K; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Chudakova DA; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Middlemiss SM; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Wen VW; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Clifton M; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Kwek A; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Liu B; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Mayoh C; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Bongers A; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Karsa M; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Pan S; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Cruikshank S; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Scandlyn M; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Hoang W; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kees UR; Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Gudkov AV; Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Chernova OB; Oncotartis, Inc., Buffalo, NY, USA.
  • Haber M; Oncotartis, Inc., Buffalo, NY, USA.
  • Norris MD; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Henderson MJ; Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
Oncotarget ; 7(29): 46067-46087, 2016 Jul 19.
Article em En | MEDLINE | ID: mdl-27317766
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios de Seleção de Medicamentos Antitumorais / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Infant Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios de Seleção de Medicamentos Antitumorais / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Infant Idioma: En Ano de publicação: 2016 Tipo de documento: Article